 Amy Huebschmann
Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 17 | 2023 | 2531 | 1.850 |
Why?
| | School Health Services | 4 | 2024 | 238 | 1.770 |
Why?
| | Exercise | 14 | 2024 | 2057 | 1.750 |
Why?
| | Asthma | 5 | 2024 | 2295 | 1.410 |
Why?
| | Primary Health Care | 15 | 2025 | 1738 | 1.300 |
Why?
| | Contraception | 2 | 2021 | 161 | 1.000 |
Why?
| | Health Equity | 2 | 2025 | 99 | 0.970 |
Why?
| | Community-Institutional Relations | 1 | 2025 | 98 | 0.890 |
Why?
| | Mass Screening | 6 | 2025 | 1287 | 0.870 |
Why?
| | Telemedicine | 3 | 2025 | 862 | 0.860 |
Why?
| | Chest Pain | 1 | 2024 | 91 | 0.840 |
Why?
| | School Nursing | 1 | 2024 | 32 | 0.840 |
Why?
| | Community-Based Participatory Research | 1 | 2025 | 162 | 0.830 |
Why?
| | Diabetes Mellitus | 5 | 2020 | 1040 | 0.810 |
Why?
| | Qualitative Research | 7 | 2024 | 1386 | 0.800 |
Why?
| | Motivation | 2 | 2018 | 570 | 0.740 |
Why?
| | Cardiovascular Diseases | 5 | 2023 | 2111 | 0.710 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2025 | 1477 | 0.670 |
Why?
| | Mentoring | 2 | 2024 | 149 | 0.660 |
Why?
| | Self-Management | 2 | 2019 | 176 | 0.660 |
Why?
| | Early Detection of Cancer | 1 | 2025 | 447 | 0.660 |
Why?
| | Couples Therapy | 1 | 2019 | 13 | 0.640 |
Why?
| | Counseling | 2 | 2014 | 391 | 0.640 |
Why?
| | Humans | 69 | 2025 | 137585 | 0.630 |
Why?
| | Research Design | 4 | 2022 | 1139 | 0.620 |
Why?
| | Health Behavior | 4 | 2024 | 762 | 0.600 |
Why?
| | Postpartum Period | 1 | 2021 | 340 | 0.580 |
Why?
| | Information Dissemination | 2 | 2023 | 218 | 0.560 |
Why?
| | Sex Factors | 5 | 2024 | 2071 | 0.530 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3284 | 0.490 |
Why?
| | Hair | 1 | 2015 | 84 | 0.470 |
Why?
| | Surveys and Questionnaires | 11 | 2025 | 5778 | 0.450 |
Why?
| | Female | 37 | 2025 | 73304 | 0.450 |
Why?
| | Caregivers | 5 | 2024 | 877 | 0.440 |
Why?
| | Patients | 3 | 2020 | 175 | 0.440 |
Why?
| | Social Determinants of Health | 4 | 2024 | 267 | 0.440 |
Why?
| | Athletes | 1 | 2018 | 423 | 0.430 |
Why?
| | Health Promotion | 3 | 2021 | 741 | 0.410 |
Why?
| | Needs Assessment | 3 | 2024 | 376 | 0.410 |
Why?
| | Professional-Patient Relations | 2 | 2012 | 145 | 0.400 |
Why?
| | Biomarkers | 1 | 2024 | 4149 | 0.400 |
Why?
| | Healthcare Disparities | 2 | 2025 | 654 | 0.390 |
Why?
| | Colorado | 8 | 2025 | 4565 | 0.390 |
Why?
| | Aged | 20 | 2025 | 23961 | 0.390 |
Why?
| | Delivery of Health Care | 5 | 2022 | 951 | 0.380 |
Why?
| | Biomedical Research | 1 | 2019 | 692 | 0.380 |
Why?
| | Hypertension | 4 | 2022 | 1295 | 0.370 |
Why?
| | Aging, Premature | 1 | 2011 | 13 | 0.370 |
Why?
| | Lung Neoplasms | 1 | 2025 | 2526 | 0.370 |
Why?
| | Interviews as Topic | 4 | 2024 | 786 | 0.360 |
Why?
| | Middle Aged | 24 | 2025 | 33479 | 0.360 |
Why?
| | Male | 30 | 2025 | 67762 | 0.350 |
Why?
| | Critical Pathways | 1 | 2012 | 96 | 0.340 |
Why?
| | Patient Preference | 2 | 2024 | 191 | 0.340 |
Why?
| | Dietary Fats | 1 | 2012 | 304 | 0.320 |
Why?
| | Perception | 2 | 2024 | 359 | 0.300 |
Why?
| | Medicare | 4 | 2022 | 773 | 0.300 |
Why?
| | Disease Management | 2 | 2015 | 628 | 0.300 |
Why?
| | Occupational Health | 2 | 2022 | 200 | 0.300 |
Why?
| | Feasibility Studies | 3 | 2022 | 956 | 0.300 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2024 | 1329 | 0.300 |
Why?
| | Adult | 24 | 2025 | 37929 | 0.290 |
Why?
| | Physical Exertion | 1 | 2009 | 215 | 0.290 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1313 | 0.280 |
Why?
| | Fear | 1 | 2011 | 338 | 0.280 |
Why?
| | Diabetic Angiopathies | 3 | 2017 | 259 | 0.280 |
Why?
| | Attitude of Health Personnel | 2 | 2024 | 1171 | 0.280 |
Why?
| | Heart Failure | 4 | 2025 | 2236 | 0.260 |
Why?
| | Patient Acceptance of Health Care | 2 | 2025 | 806 | 0.260 |
Why?
| | Electronic Health Records | 3 | 2025 | 1069 | 0.260 |
Why?
| | Social Support | 3 | 2024 | 618 | 0.250 |
Why?
| | Glycation End Products, Advanced | 1 | 2006 | 82 | 0.240 |
Why?
| | Physicians | 3 | 2023 | 910 | 0.230 |
Why?
| | United States | 11 | 2025 | 14841 | 0.230 |
Why?
| | Vascular Stiffness | 2 | 2023 | 494 | 0.230 |
Why?
| | Chronic Disease | 4 | 2024 | 1793 | 0.230 |
Why?
| | Adolescent | 10 | 2024 | 21513 | 0.230 |
Why?
| | Troponin | 1 | 2024 | 50 | 0.220 |
Why?
| | Point-of-Care Systems | 2 | 2020 | 167 | 0.220 |
Why?
| | Troponin T | 1 | 2024 | 65 | 0.220 |
Why?
| | Narration | 1 | 2024 | 58 | 0.220 |
Why?
| | Troponin I | 1 | 2024 | 81 | 0.210 |
Why?
| | Transportation | 1 | 2024 | 53 | 0.210 |
Why?
| | Social Isolation | 1 | 2024 | 62 | 0.210 |
Why?
| | Vulnerable Populations | 1 | 2024 | 163 | 0.200 |
Why?
| | Oxygen | 2 | 2018 | 931 | 0.200 |
Why?
| | Mental Health | 3 | 2024 | 726 | 0.190 |
Why?
| | Cross-Sectional Studies | 8 | 2021 | 5472 | 0.190 |
Why?
| | Peer Group | 1 | 2024 | 242 | 0.190 |
Why?
| | Hospice and Palliative Care Nursing | 1 | 2023 | 75 | 0.190 |
Why?
| | Leg | 2 | 2021 | 236 | 0.180 |
Why?
| | Mental Health Services | 2 | 2025 | 421 | 0.180 |
Why?
| | Government Programs | 1 | 2021 | 25 | 0.180 |
Why?
| | Ambulatory Care | 1 | 2025 | 546 | 0.180 |
Why?
| | Child | 9 | 2024 | 21935 | 0.180 |
Why?
| | Health Care Surveys | 2 | 2014 | 565 | 0.170 |
Why?
| | Psychometrics | 1 | 2025 | 720 | 0.170 |
Why?
| | Contraceptive Agents | 1 | 2021 | 66 | 0.170 |
Why?
| | Program Evaluation | 1 | 2025 | 898 | 0.170 |
Why?
| | Oxygen Consumption | 6 | 2021 | 696 | 0.170 |
Why?
| | Oxidative Phosphorylation | 2 | 2019 | 193 | 0.170 |
Why?
| | Patient Navigation | 1 | 2022 | 81 | 0.170 |
Why?
| | Multiple Chronic Conditions | 1 | 2020 | 29 | 0.170 |
Why?
| | Decision Support Systems, Clinical | 1 | 2023 | 226 | 0.160 |
Why?
| | Guatemala | 1 | 2021 | 327 | 0.160 |
Why?
| | Home Care Services | 1 | 2023 | 257 | 0.160 |
Why?
| | Precision Medicine | 1 | 2024 | 429 | 0.160 |
Why?
| | Social Welfare | 1 | 2019 | 26 | 0.160 |
Why?
| | Influenza Vaccines | 1 | 2024 | 539 | 0.160 |
Why?
| | Pilot Projects | 3 | 2024 | 1710 | 0.160 |
Why?
| | Community Mental Health Services | 1 | 2020 | 84 | 0.160 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 12 | 0.160 |
Why?
| | Dementia | 1 | 2023 | 259 | 0.160 |
Why?
| | Social Work | 1 | 2020 | 85 | 0.160 |
Why?
| | Palliative Care | 2 | 2023 | 758 | 0.160 |
Why?
| | Cancer Survivors | 1 | 2024 | 285 | 0.160 |
Why?
| | Patient Care Planning | 1 | 2020 | 157 | 0.160 |
Why?
| | Health Personnel | 2 | 2024 | 710 | 0.160 |
Why?
| | Sitagliptin Phosphate | 1 | 2019 | 33 | 0.150 |
Why?
| | Intimate Partner Violence | 1 | 2021 | 91 | 0.150 |
Why?
| | Socioeconomic Factors | 2 | 2015 | 1289 | 0.150 |
Why?
| | Diastole | 1 | 2019 | 149 | 0.150 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 47 | 0.150 |
Why?
| | Cardiorespiratory Fitness | 1 | 2019 | 55 | 0.150 |
Why?
| | Accelerometry | 1 | 2019 | 103 | 0.150 |
Why?
| | Patient Care Team | 2 | 2022 | 631 | 0.150 |
Why?
| | Inpatients | 1 | 2023 | 500 | 0.150 |
Why?
| | Schools | 1 | 2022 | 461 | 0.150 |
Why?
| | Influenza, Human | 1 | 2024 | 622 | 0.150 |
Why?
| | Exercise Tolerance | 2 | 2017 | 279 | 0.140 |
Why?
| | Cardiovascular System | 1 | 2019 | 137 | 0.140 |
Why?
| | Focus Groups | 2 | 2023 | 522 | 0.140 |
Why?
| | Cultural Characteristics | 1 | 2018 | 67 | 0.140 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2017 | 65 | 0.140 |
Why?
| | Checklist | 1 | 2018 | 93 | 0.140 |
Why?
| | Health Services Accessibility | 2 | 2024 | 986 | 0.140 |
Why?
| | Health Care Costs | 1 | 2020 | 398 | 0.130 |
Why?
| | Hypoglycemic Agents | 3 | 2019 | 1291 | 0.130 |
Why?
| | Patient Satisfaction | 2 | 2019 | 660 | 0.130 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 116 | 0.130 |
Why?
| | Ultrasonography | 1 | 2020 | 759 | 0.130 |
Why?
| | Venoms | 1 | 2016 | 29 | 0.130 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2016 | 36 | 0.130 |
Why?
| | Research Personnel | 1 | 2018 | 173 | 0.130 |
Why?
| | Microvessels | 1 | 2017 | 88 | 0.130 |
Why?
| | Vaccination | 1 | 2024 | 1381 | 0.120 |
Why?
| | Muscle, Skeletal | 4 | 2021 | 1724 | 0.120 |
Why?
| | Self Efficacy | 1 | 2019 | 396 | 0.120 |
Why?
| | Blood Vessels | 1 | 2017 | 187 | 0.120 |
Why?
| | Lung Diseases | 1 | 2022 | 767 | 0.120 |
Why?
| | Sex Characteristics | 2 | 2022 | 762 | 0.120 |
Why?
| | Quality Improvement | 1 | 2023 | 1178 | 0.110 |
Why?
| | American Heart Association | 1 | 2015 | 306 | 0.110 |
Why?
| | Risk Factors | 3 | 2020 | 10388 | 0.110 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2016 | 382 | 0.100 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7635 | 0.100 |
Why?
| | Faculty | 1 | 2014 | 147 | 0.100 |
Why?
| | Interprofessional Relations | 1 | 2015 | 283 | 0.100 |
Why?
| | Pandemics | 1 | 2021 | 1639 | 0.100 |
Why?
| | Incidence | 1 | 2019 | 2804 | 0.100 |
Why?
| | Prospective Studies | 3 | 2021 | 7604 | 0.100 |
Why?
| | Prevalence | 1 | 2019 | 2734 | 0.100 |
Why?
| | Pharmacists | 1 | 2015 | 265 | 0.100 |
Why?
| | Cooperative Behavior | 1 | 2015 | 451 | 0.090 |
Why?
| | Attitude to Health | 1 | 2015 | 439 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2024 | 2253 | 0.090 |
Why?
| | Internal Medicine | 1 | 2014 | 265 | 0.090 |
Why?
| | Women's Health | 1 | 2014 | 372 | 0.090 |
Why?
| | Stroke Volume | 2 | 2025 | 612 | 0.090 |
Why?
| | Psychotherapy | 1 | 2012 | 167 | 0.090 |
Why?
| | Dietary Carbohydrates | 1 | 2012 | 155 | 0.090 |
Why?
| | Exercise Test | 2 | 2015 | 625 | 0.090 |
Why?
| | Antidepressive Agents | 1 | 2012 | 236 | 0.090 |
Why?
| | Peptides | 1 | 2016 | 985 | 0.090 |
Why?
| | Plant Preparations | 1 | 2010 | 36 | 0.080 |
Why?
| | Health Expenditures | 1 | 2012 | 189 | 0.080 |
Why?
| | Nonprescription Drugs | 1 | 2010 | 63 | 0.080 |
Why?
| | Workplace | 2 | 2022 | 261 | 0.080 |
Why?
| | Depressive Disorder | 1 | 2012 | 379 | 0.080 |
Why?
| | Pulse Wave Analysis | 2 | 2023 | 272 | 0.080 |
Why?
| | Comparative Effectiveness Research | 1 | 2010 | 152 | 0.080 |
Why?
| | Obesity | 2 | 2023 | 2992 | 0.080 |
Why?
| | Patient Education as Topic | 1 | 2014 | 766 | 0.080 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 494 | 0.070 |
Why?
| | Patient Compliance | 1 | 2012 | 581 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2057 | 0.070 |
Why?
| | Guideline Adherence | 1 | 2012 | 556 | 0.070 |
Why?
| | Prejudice | 1 | 2007 | 73 | 0.070 |
Why?
| | Disclosure | 1 | 2007 | 113 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2016 | 5131 | 0.070 |
Why?
| | Diabetes, Gestational | 1 | 2011 | 318 | 0.070 |
Why?
| | Walking | 1 | 2011 | 529 | 0.060 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2006 | 33 | 0.060 |
Why?
| | Nebraska | 1 | 2025 | 18 | 0.060 |
Why?
| | Wyoming | 1 | 2025 | 36 | 0.060 |
Why?
| | Medicaid | 2 | 2019 | 435 | 0.060 |
Why?
| | Hypoglycemia | 1 | 2010 | 445 | 0.060 |
Why?
| | Mothers | 1 | 2011 | 754 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2006 | 216 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 3295 | 0.050 |
Why?
| | Regional Blood Flow | 2 | 2017 | 474 | 0.050 |
Why?
| | Internship and Residency | 1 | 2014 | 1147 | 0.050 |
Why?
| | Safety-net Providers | 1 | 2024 | 119 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2019 | 1993 | 0.050 |
Why?
| | Cardiology | 1 | 2025 | 274 | 0.050 |
Why?
| | Delphi Technique | 1 | 2024 | 280 | 0.050 |
Why?
| | Patient Care | 1 | 2023 | 111 | 0.050 |
Why?
| | Longevity | 1 | 2022 | 165 | 0.040 |
Why?
| | Aorta, Thoracic | 1 | 2023 | 267 | 0.040 |
Why?
| | Aging | 1 | 2011 | 1864 | 0.040 |
Why?
| | Small Business | 1 | 2021 | 51 | 0.040 |
Why?
| | Point-of-Care Testing | 1 | 2020 | 32 | 0.040 |
Why?
| | Internet | 1 | 2024 | 655 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 548 | 0.040 |
Why?
| | Sulfonylurea Compounds | 1 | 2019 | 48 | 0.040 |
Why?
| | Placebos | 1 | 2019 | 199 | 0.040 |
Why?
| | Self Care | 1 | 2022 | 380 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1783 | 0.040 |
Why?
| | Goals | 1 | 2020 | 170 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 558 | 0.040 |
Why?
| | Young Adult | 2 | 2012 | 13209 | 0.040 |
Why?
| | Poverty | 1 | 2022 | 521 | 0.040 |
Why?
| | Emergency Service, Hospital | 2 | 2019 | 2069 | 0.040 |
Why?
| | Cell Respiration | 1 | 2018 | 103 | 0.040 |
Why?
| | Consensus | 1 | 2021 | 683 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 99 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2022 | 553 | 0.030 |
Why?
| | Capillary Resistance | 1 | 2017 | 5 | 0.030 |
Why?
| | Oxyhemoglobins | 1 | 2017 | 23 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2012 | 10811 | 0.030 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2017 | 59 | 0.030 |
Why?
| | Microcirculation | 1 | 2017 | 149 | 0.030 |
Why?
| | Publishing | 1 | 2018 | 147 | 0.030 |
Why?
| | Bicycling | 1 | 2017 | 114 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 792 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2025 | 15657 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2017 | 375 | 0.030 |
Why?
| | Communication | 1 | 2022 | 879 | 0.030 |
Why?
| | Parents | 1 | 2024 | 1347 | 0.030 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2016 | 135 | 0.030 |
Why?
| | Infant | 2 | 2024 | 9465 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1077 | 0.030 |
Why?
| | Hemoglobins | 1 | 2017 | 353 | 0.030 |
Why?
| | Ventricular Function | 1 | 2015 | 61 | 0.030 |
Why?
| | Arteries | 1 | 2016 | 269 | 0.030 |
Why?
| | Forearm | 1 | 2015 | 119 | 0.030 |
Why?
| | Endothelium | 1 | 2015 | 123 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 11074 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1317 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 108 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2015 | 199 | 0.030 |
Why?
| | Blood Pressure | 1 | 2021 | 1786 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2844 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2018 | 443 | 0.030 |
Why?
| | Brachial Artery | 1 | 2015 | 205 | 0.030 |
Why?
| | Reaction Time | 1 | 2015 | 412 | 0.030 |
Why?
| | Lung Diseases, Obstructive | 1 | 2012 | 50 | 0.020 |
Why?
| | Pediatrics | 1 | 2020 | 1101 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 2892 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2016 | 788 | 0.020 |
Why?
| | Vasodilation | 1 | 2015 | 499 | 0.020 |
Why?
| | Kinetics | 1 | 2015 | 1670 | 0.020 |
Why?
| | Mexico | 1 | 2011 | 225 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3457 | 0.020 |
Why?
| | Computer Communication Networks | 1 | 2010 | 33 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2016 | 927 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2015 | 786 | 0.020 |
Why?
| | Blood Glucose | 1 | 2019 | 2186 | 0.020 |
Why?
| | Emigrants and Immigrants | 1 | 2011 | 136 | 0.020 |
Why?
| | Comorbidity | 1 | 2012 | 1622 | 0.020 |
Why?
| | Homosexuality, Female | 1 | 2007 | 39 | 0.020 |
Why?
| | Public Opinion | 1 | 2007 | 65 | 0.020 |
Why?
| | Logistic Models | 1 | 2012 | 2074 | 0.020 |
Why?
| | Data Collection | 1 | 2010 | 673 | 0.020 |
Why?
| | Models, Statistical | 1 | 2011 | 669 | 0.020 |
Why?
| | Homosexuality, Male | 1 | 2007 | 184 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2015 | 1208 | 0.020 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 698 | 0.020 |
Why?
| | Pregnancy | 1 | 2011 | 6763 | 0.010 |
Why?
|
|
Huebschmann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|